🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

13,540 results for “B” Clear

  1. 0.9% Sodium Chloride for Injection, KEYTRUDA 25 mg/mL concentrate for solution for infusion, KEYTRUDA 25 mg/mL concentrate for solution for infusion., JEMPERLI 500 mg concentrate for solution for infusion

    GlaxoSmithKline Biologicals S.A.

    Lung Cancer, Non-Small Cell

    phase 3 small molecule active

    1 trial

  2. 0.9% Sodium Chloride, JNJ-78901563

    Janssen Pharmaceutica N.V.

    Invasive Extraintestinal Pathogenic Escherichia coli Disease

    phase 3 small molecule active

    1 trial

  3. 0.9% Sodium chloride, Amvuttra 25 mg solution for injection in pre-filled syringe

    Alnylam Netherlands B.V.

    Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)

    phase 3 small molecule active

    1 trial

  4. 0.9% sodium chloride, GB-0895

    Generate Biomedicines

    severe uncontrolled asthma

    phase 3 small molecule active

    1 trial

  5. 1% Clascoterone Cream

    Sunshine Biopharma

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  6. 1.0mg/kg/day PRAX-562

    PRECISION BIOSCIENCES INC

    Developmental and Epileptic Encephalopathy 1

    phase 3 small molecule active

    1 trial

  7. 10-week smoking cessation group therapy combined with NicoDerm CQ

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    phase 3 other completed

    1 trial

  8. 11C-SB207145, 11C-DASB

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Parkinson's disease, Prodromal phase of Parkinson's disease

    phase 3 small molecule active

    1 trial

  9. 12-Valent Pneumococcal Conjugate Vaccine

    MAIA Biotechnology

    Pneumococcal Vaccines

    phase 3 mab active

    1 trial

  10. 131I-apamistamab

    Actinium Pharmaceuticals

    Acute Leukemia

    phase 3 small molecule active

    1 trial

  11. 18F fluciclovine

    PRECISION BIOSCIENCES INC

    Brain Metastases

    phase 3 small molecule completed

    2 trials

  12. 18F-AV-1451

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Maladie d' Alzheimer, Alzheimer's pathology

    phase 3 small molecule active

    1 trial

  13. 18F-DPA-714

    Pari Pharma GmbH

    Multiple sclerosis

    phase 3 small molecule active

    1 trial

  14. 18F-LBT-999

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Comatose Traumatic Brain Injury patients

    phase 3 small molecule active

    1 trial

  15. 1:1:1 Blood Transfusion Ratio

    United Therapeutics Europe Ltd

    Trauma

    phase 3 mab completed

    1 trial

  16. 1mg elsunersen

    PRECISION BIOSCIENCES INC

    Epileptic Encephalopathy

    phase 3 small molecule active

    1 trial

  17. 2 cycles induction chemotherapy

    First Tracks Biotherapeutics

    Locally Advanced Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  18. 2-mg Intravitreous Aflibercept Injection

    Regeneron UK Limited

    Proliferative Diabetic Retinopathy

    phase 3 small molecule completed

    1 trial

  19. 2.0 mg intravitreal aflibercept

    Regeneron UK Limited

    Diabetic Macular Edema

    phase 3 small molecule completed

    1 trial

  20. 20 mg VEC-162

    Vanda Pharmaceuticals Netherlands B.V.

    Insomnia

    phase 3 small molecule completed

    1 trial

  21. 20 mg sildenafil citrate by mouth

    First Tracks Biotherapeutics

    Pulmonary Hypertension

    phase 3 small molecule active

    1 trial

  22. 20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks

    PRECISION BIOSCIENCES INC

    Focal Seizure

    phase 3 small molecule active

    1 trial

  23. 25 mg Ontamalimab

    Takeda Pharmaceuticals International AG

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  24. 2mg Baricitinib

    China SXT Pharmaceuticals

    Acute Ichemic Stroke

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources